Our Products
Our offered Product range includes Abraxane 100mg Injection, Herclon 440mg Injection, Abraxane Injection and Aclasta Injection.
Our Abraxane 100mg Injection offers a different approach for treating breast cancer with paclitaxel by using an albumin formulation to deliver the paclitaxel. Albumin is a human protein that carries nutrients throughout the body. The Abraxane 100mg Injection, offered by us, is a prescription drug and should be used under proper medical guidance and advice. Prescribed for some types of brain tumors, our Abraxane 100mg Injection stops the growth of the cells that cause cancer.
Herclon 440mg Injection contains trastuzumab (canmab) which is used for treating breast cancer. Canmab is a monoclonal antibody, which interferes with the her receptor. The her receptor is a kind of proteins that are embedded in the cell membrane.
Abraxane Injection Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) is paclitaxel formulated as albumin-bound nanoparticles with a mean particle size of approximately 130 nanometers. Paclitaxel exists in the particles in a non-crystalline, amorphous state. ABRAXANE is supplied as a white to yellow, sterile, lyophilized powder for reconstitution with 20 mL of 0.9% Sodium Chloride Injection, USP prior to intravenous infusion. Each single-use vial contains 100 mg of paclitaxel (bound to human albumin) and approximately 900 mg of human albumin (containing sodium caprylate and sodium acetyltryptophanate). Each milliliter (mL) of reconstituted suspension contains 5 mg paclitaxel formulated as albumin-bound particles. ABRAXANE is free of solvents.